Part 8: Stabilization of the Patient With Acute Coronary Syndromes

Acute myocardial infarction (AMI) and unstable angina (UA) are part of a spectrum of clinical disease collectively identified as acute coronary syndromes (ACS). The pathophysiology common to this spectrum of disease is a ruptured or eroded atheromatous plaque.1–5 The electrocardiographic (ECG) presentation of these syndromes encompasses ST-segment elevation myocardial infarction (STEMI), ST-segment depression, and nondiagnostic ST-segment and T-wave abnormalities. A non–ST-elevation myocardial infarction (NSTEMI) is diagnosed if cardiac markers are positive with ST-segment depression or with nonspecific or normal ECGs. Sudden cardiac death may occur with any of these conditions. ACS is the most common proximate cause of sudden cardiac death.6–10 Effective interventions for patients with ACS, particularly STEMI, are extremely time-sensitive. The first healthcare providers to encounter the ACS patient can have a big impact on patient outcome if they provide efficient risk stratification, initial stabilization, and referral for cardiology care. It is critical that basic life support (BLS) and advanced cardiovascular life support (ACLS) healthcare providers who care for ACS patients in the out-of-hospital, emergency department (ED), and hospital environments be aware of the principles and priorities of assessment and stabilization of these patients. These guidelines target BLS and ACLS healthcare providers who treat patients with ACS within the first hours after onset of symptoms, summarizing key out-of-hospital, ED, and some initial critical-care topics that are relevant to stabilization. They also continue to build on recommendations from the ACC/AHA Guidelines,11,12 which are used throughout the United States and Canada.13 As with any medical guidelines, these general recommendations must be considered within the context of local resources and application to individual patients by knowledgeable healthcare providers. The primary goals of therapy for patients with ACS are to

[1]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[2]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[3]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[4]  D. Pahlajani,et al.  Comparison of clinical outcome of fixed-dose subcutaneous low molecular weight heparin (tinzaparin) with conventional heparin in unstable angina: a pilot study. , 1997, Indian heart journal.

[5]  R. Virmani,et al.  Plaque rupture and sudden death related to exertion in men with coronary artery disease. , 1999, JAMA.

[6]  R. Califf,et al.  Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. , 1995, Circulation.

[7]  T. Meinertz,et al.  Prehospital testing for troponin T in patients with suspected acute myocardial infarction. , 1999, American heart journal.

[8]  R. Fitzgerald,et al.  Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. , 2001, The American journal of cardiology.

[9]  R. Collins,et al.  Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) , 1995, The Lancet.

[10]  K. Coyne,et al.  Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin: Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II) , 2001, Circulation.

[11]  Raymond C. Schneider,et al.  ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.

[12]  R. Collins,et al.  ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials. , 1993, The American journal of cardiology.

[13]  E. Vicaut,et al.  Independent role of arterial O2 tension in local control of coronary blood flow. , 1990, The American journal of physiology.

[14]  F Rovelli,et al.  Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators. , 1998, Circulation.

[15]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al.  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[16]  R. Collins,et al.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.

[17]  C. Wilson,et al.  Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. , 2002, European heart journal.

[18]  E. Braunwald,et al.  Effects of hypoxemia on the extent of myocardial necrosis after experimental coronary occlusion. , 1975, The American journal of cardiology.

[19]  R. Virmani,et al.  Plaque morphology in sudden coronary death. , 1998, Cardiologia.

[20]  D. Moser,et al.  Women's decision to seek care for symptoms of acute myocardial infarction. , 1995, Heart & lung : the journal of critical care.

[21]  T. Feldman,et al.  Evaluation of patients for the need of thrombolytic therapy in the prehospital setting. , 1989, Annals of emergency medicine.

[22]  S. Solomon,et al.  Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. , 1997, Circulation.

[23]  R. Califf,et al.  Relation of Increased Arterial Blood Pressure to Mortality and Stroke in the Context of Contemporary Thrombolytic Therapy for Acute Myocardial Infarction , 1996, Annals of Internal Medicine.

[24]  J. Vítovec,et al.  First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction. , 2000, International journal of cardiology.

[25]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. , 1995, The New England journal of medicine.

[26]  J. Canto,et al.  Safety and effectiveness of combined low molecular weight heparin and glycoprotein IIb/IIIa inhibitors. , 2002, The American journal of cardiology.

[27]  C. Vassanelli,et al.  [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[28]  R. Califf,et al.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[29]  C. Maynard,et al.  Prehospital ECG transmission speeds reperfusion for patients with acute myocardial infarction. , 2000, North Carolina medical journal.

[30]  A. M. Skene,et al.  TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.

[31]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[32]  Paul Dorian,et al.  The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. , 2004, The Canadian journal of cardiology.

[33]  H. White,et al.  Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study☆☆☆★ , 2002 .

[34]  岡田 和夫,et al.  話題 「Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care--International Consensus on Science」の日本における普及と取り組み , 2001 .

[35]  Study,et al.  Oral captopril versus placebo among 14962 patients with suspected acute myocardial infarction: a multicenter,randomized,double-blind,placebo controlled clinical trial , 1997 .

[36]  V. Fuster Elucidation of the role of plaque instability and rupture in acute coronary events. , 1995, The American journal of cardiology.

[37]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[38]  J. Salerno Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). , 1986, Lancet.

[39]  J. Rawles Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). , 1994, Journal of the American College of Cardiology.

[40]  T. Aufderheide,et al.  Feasibility of prehospital r-TPA therapy in chest pain patients. , 1992, Annals of emergency medicine.

[41]  B. Lilja,et al.  Effects of oxygen on acute myocardial infarction: a thermographic study in the dog. , 1977, Cardiovascular research.

[42]  Bridget Wilcken,et al.  Pathogenesis of coronary artery disease , 1969 .

[43]  G. Peirce,et al.  Polarographic Oxygen, the Epicardial Electrocardiogram and Muscle Contraction in Experimental Acute Regional Ischemia of the Left Ventricle , 1958, Circulation research.

[44]  Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. American College of Emergency Physicians. , 2000, Annals of emergency medicine.

[45]  R. Gibbons,et al.  Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. , 2002, European heart journal.

[46]  B. Brodie,et al.  Importance of infarct-related artery patency for recovery of left ventricular function and late survival after primary angioplasty for acute myocardial infarction. , 1996, Journal of the American College of Cardiology.

[47]  S. Egaas A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction , 1997 .

[48]  R. Collins,et al.  Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. , 1988, JAMA.

[49]  Harlan M Krumholz,et al.  Times to Treatment in Transfer Patients Undergoing Primary Percutaneous Coronary Intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 Analysis , 2005, Circulation.

[50]  J. Herlitz,et al.  Limitation of infarct size by beta blockers and its potential role for prognosis. , 1983, Circulation.

[51]  K. Lee,et al.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.

[52]  T. Aufderheide,et al.  The diagnostic impact of prehospital 12-lead electrocardiography. , 1989, Annals of emergency medicine.

[53]  V. Fuster,et al.  Pathogenesis of thrombosis in coronary artery disease. , 1997, Haemostasis.

[54]  T. Investigators,et al.  A comparison of reteplase with alteplase for acute myocardial infarction , 1997 .

[55]  W. Rogers,et al.  Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.

[56]  Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation , 2001, Heart.

[57]  D. Brieger,et al.  Optimal strategy for administering enoxaparin to patients undergoing coronary angiography without angioplasty for acute coronary syndromes. , 2002, The American journal of cardiology.

[58]  R. Wilcox Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence: International Joint Efficacy Comparison of Thrombolytics , 1995 .

[59]  L. S. Group Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction , 1993, The Lancet.

[60]  W. Weaver,et al.  Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). MITI Project Investigators. , 1996, The American journal of cardiology.

[61]  K. Swedberg,et al.  Göteborg Metoprolol Trial: effects on arrhythmias. , 1984, The American journal of cardiology.

[62]  J. Ioannidis,et al.  Accuracy and clinical effect of out-of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a meta-analysis. , 2001, Annals of emergency medicine.

[63]  M. Bourassa,et al.  The effects of inhalation of 100 percent oxygen on myocardial lactate metabolism in coronary heart disease. , 1969, The American journal of cardiology.

[64]  Oral captopril versus placebo among 14,962 patients with suspected acute myocardial infarction: a multicenter, randomized, double-blind, placebo controlled clinical trial. Chinese Cardiac Study (CCS-1) Collaborative Group. , 1997, Chinese medical journal.

[65]  T. Feldman,et al.  Cellular telephone transmission of 12-lead electrocardiograms from ambulance to hospital. , 1987, The American journal of cardiology.

[66]  M. Dalby,et al.  Transfer for Primary Angioplasty Versus Immediate Thrombolysis in Acute Myocardial Infarction: A Meta-Analysis , 2003, Circulation.

[67]  Johan Herlitz,et al.  Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group. , 1985, European heart journal.

[68]  J. Herlitz,et al.  Elevation of biochemical markers for myocardial damage prior to hospital admission in patients with acute chest pain or other symptoms raising suspicion of acute coronary syndrome , 2003, Journal of internal medicine.

[69]  Klaus Rasmussen,et al.  A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.

[70]  F. Fabris,et al.  Heparin-induced thrombocytopenia. , 2000, Haematologica.

[71]  D. Moser,et al.  Women’s Early Warning Symptoms of Acute Myocardial Infarction , 2003, Circulation.

[72]  E. Braunwald,et al.  Reduction of Infarct Size by Oxygen Inhalation Following Acute Coronary Occlusion , 1975, Circulation.

[73]  P. Kudenchuk,et al.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. , 1993, JAMA.

[74]  R. Beale,et al.  Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. , 1993, JAMA.

[75]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .

[76]  W. Weaver,et al.  Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1. , 1997, Archives of internal medicine.

[77]  B. Magnani,et al.  Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party. , 1998, American heart journal.

[78]  E. Topol A comparison of reteplase with alteplase for acute myocardial infarction. , 1998, The New England journal of medicine.

[79]  I. Ford,et al.  Early treatment with captopril after acute myocardial infarction. , 1993, British heart journal.

[80]  R. Gibbons,et al.  Clinical characteristics and outcome of patients with early ( 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. , 2002 .

[81]  J. Gore,et al.  Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). , 1998, Journal of the American College of Cardiology.

[82]  J. Greenfield,et al.  Effect of hyperoxia on regional blood flow after coronary occlusion in awake dogs. , 1980, The American journal of physiology.

[83]  Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group. , 1988, JAMA.

[84]  J. Alpert,et al.  Temporal trends (1975 through 1990) in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction. A communitywide perspective. , 1994, Circulation.

[85]  M. Legato Coronary artery disease in women. , 1996, International journal of fertility and menopausal studies.

[86]  E. Cook,et al.  Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: the Multicenter Chest Pain Study experience. , 1989, The American journal of cardiology.

[87]  J. W. Schaeffer,et al.  ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina) , 2000 .

[88]  Paolo Berger,et al.  Randomized, double blind comparison of reteplase double bolus administration with streptokinase in acute myocardial infarction (inject): Trial to investigate equivalence , 1996 .

[89]  R. Fitzgerald,et al.  Ninety-minute accelerated critical pathway for chest pain evaluation. , 2001, The American journal of cardiology.

[90]  S. Banerjee,et al.  Fast-tracking of Myocardial Infarction by Paramedics , 1998, Journal of the Royal College of Physicians of London.

[91]  S. Black,et al.  Alterations in Endogenous Nitric Oxide Production After Cardiopulmonary Bypass in Lambs With Normal and Increased Pulmonary Blood Flow , 2000, Circulation.

[92]  L. Morrison,et al.  Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. , 2000, JAMA.

[93]  Fibrinolytic Therapy Trialists' Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994, The Lancet.

[94]  E. Antman,et al.  Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.

[95]  F. Sheehan,et al.  The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. , 1988, Circulation.

[96]  A. Skene,et al.  Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. , 2005, The New England journal of medicine.

[97]  R. Califf,et al.  Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. , 1998, Circulation.

[98]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[99]  S. Cannizzaro,et al.  Does captopril treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-term and long-term effects. , 1994, International journal of cardiology.

[100]  S. Clark,et al.  Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery. , 2000, The Annals of thoracic surgery.

[101]  R. Kloner,et al.  Cardioprotective effects of captopril in myocardial ischaemia, ischaemia/reperfusion and infarction. , 1990, European heart journal.

[102]  E. Braunwald,et al.  Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators. , 1999, American heart journal.

[103]  K A Eagle,et al.  ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro , 2001, Journal of the American College of Cardiology.

[104]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[105]  S. Yusuf,et al.  Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial , 2004, Circulation.

[106]  P. Armstrong,et al.  Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. , 2003, Circulation.

[107]  M. Flather,et al.  ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. , 1995, Circulation.

[108]  J S Martin,et al.  Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy. MITI Project Investigators. , 1991, Journal of the American College of Cardiology.

[109]  D. Moliterno,et al.  Aspirin, ticlopidine, and clopidogrel in acute coronary syndromes: underused treatments could save thousands of lives. , 1999, Cleveland Clinic journal of medicine.

[110]  Steve Goodacre,et al.  How useful are clinical features in the diagnosis of acute, undifferentiated chest pain? , 2002, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[111]  E. Antman,et al.  Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. , 2002, European heart journal.

[112]  R. Collins,et al.  Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab , 2000, Journal of the American College of Cardiology.

[113]  D. Clement A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[114]  J. Anderson,et al.  Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. , 1990, The American journal of cardiology.

[115]  E. Braunwald,et al.  Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. , 1990, Journal of the American College of Cardiology.

[116]  M. Kayıkçıoğlu,et al.  Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty. , 2002, Acta cardiologica.

[117]  R. Gibbons,et al.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. , 1998, JAMA.

[118]  G. Ginsburg,et al.  The evaluation of chest pain in women. , 1996, The New England journal of medicine.

[119]  Early angiography and angioplasty following thrombolytic therapy of acute myocardial infarction. Metaanalysis of the randomized control trials. , 1993, The Online journal of current clinical trials.

[120]  C. Y. Lu [Treatment of acute myocardial infarction with oral captopril. A randomized, double blind and placebo controlled pilot study]. , 1993, Zhonghua xin xue guan bing za zhi.

[121]  S. Yusuf,et al.  Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study , 2003, Circulation.

[122]  E. Falk Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.

[123]  M. Aschermann,et al.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. , 2003, European heart journal.

[124]  M. Keltai,et al.  Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome). , 1999, European heart journal.

[125]  F. Fernández‐Avilés,et al.  Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial , 2004, The Lancet.

[126]  N. Powe,et al.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. , 2000, Circulation.

[127]  E. Topol,et al.  Prehospital administration of aspirin in patients with unstable angina and acute myocardial infarction. , 1996, Archives of internal medicine.

[128]  E. Ambrosioni,et al.  Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. , 2003, American heart journal.

[129]  Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. , 1993, The New England journal of medicine.

[130]  J. Mead,et al.  Studies of coronary disease in the experimental animal. II. Polarographic determinations of local oxygen availability in the dog's left ventricle during coronary occlusion and pure oxygen breathing. , 1951, The Journal of clinical investigation.

[131]  T. Investigators Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.

[132]  Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. , 1998, The New England journal of medicine.

[133]  T. Takano,et al.  Cardiac emergency triage and therapeutic decisions using whole blood rapid troponin T test for patients with suspicious acute coronary syndrome. , 2001, Japanese circulation journal.

[134]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[135]  L. Deckelbaum,et al.  Combination therapy with tirofiban and enoxaparin in acute coronary syndromes. , 1999, International journal of cardiology.

[136]  G. Hobbs,et al.  Prehospital identification of acute coronary ischemia using a troponin T rapid assay. , 1999, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[137]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[138]  V. Hasselblad,et al.  Interventional cardiology: abstractEfficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: A systematic overview☆ , 2004 .

[139]  J S Geddes,et al.  A mobile intensive-care unit in the management of myocardial infarction. , 1967, Lancet.

[140]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[141]  Emergency department: rapid identification and treatment of patients with acute myocardial infarction. National Heart Attack Alert Program Coordinating Committee, 60 Minutes to Treatment Working Group. , 1994, Annals of emergency medicine.

[142]  P J Scanlon,et al.  ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and , 1999, Circulation.

[143]  A. Murray,et al.  Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. , 1981, British heart journal.

[144]  D. Simons-Morton,et al.  Access to Timely and Optimal Care of Patients with Acute Coronary Syndromes — Community Planning Considerations: A Report by the National Heart Attack Alert Program , 1998, Journal of Thrombosis and Thrombolysis.

[145]  E. Martin,et al.  Bedside troponin T testing is not useful for early out‐of‐hospital diagnosis of myocardial infarction , 1998, Acta anaesthesiologica Scandinavica.

[146]  P. Touboul,et al.  Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.

[147]  S. Goodacre,et al.  Clinical predictors of acute coronary syndromes in patients with undifferentiated chest pain. , 2003, QJM : monthly journal of the Association of Physicians.

[148]  E R Bates,et al.  Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.

[149]  R. Califf,et al.  Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.

[150]  T. Killip,et al.  Arterial oxygen tension in acute myocardial infarction. Serial analysis of clinical state and blood gas changes. , 1970, American Heart Journal.

[151]  M. Melville,et al.  The Potential Impact of Prehospital Electrocardiography and Telemetry on Time to Thrombolysis in a United Kingdom Center , 1998 .

[152]  R. Zahn,et al.  The volume of primary angioplasty procedures and survival after acute myocardial infarction. , 2000, The New England journal of medicine.

[153]  R. Luepker,et al.  Reaction to a media campaign focusing on delay in acute myocardial infarction. , 1991, Heart & lung : the journal of critical care.

[154]  V. Verdile,et al.  E DUCATION OF P ARAMEDICS R EGARDING A SPIRIN U SE , 2000, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[155]  R. Califf,et al.  Individual risk assessment for intracranial haemorrhage during thrombolytic therapy , 1993, The Lancet.

[156]  E. Topol,et al.  Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV—Acute Coronary Syndrome) Trial , 2003, Circulation.

[157]  E. Antman,et al.  Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. , 2000, Circulation.

[158]  S. Yusuf,et al.  Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. , 1995, Circulation.

[159]  A. Connor,et al.  The way I see it: House officers need formal career development , 2002 .

[160]  E. Braunwald,et al.  Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. , 1999, Circulation.

[161]  R. Califf,et al.  Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. , 1999, Circulation.

[162]  Harry P. Selker,et al.  A Tool for Judging Coronary Care Unit Admission Appropriateness, Valid for Both Real-Time and Retrospective Use: A Time-Insensitive Predictive Instrument (TIPI) for Acute Cardiac Ischemia: A Multicenter Study , 1991, Medical care.

[163]  T. Aufderheide,et al.  A prospective evaluation of prehospital 12-lead ECG application in chest pain patients. , 1992, Journal of electrocardiology.

[164]  W. Rogers,et al.  The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.

[165]  J. Gaspoz,et al.  Time savings with prehospital thrombolysis in an urban area , 2003, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[166]  N. Rehnqvist,et al.  Metoprolol in acute myocardial infarction reduces ventricular arrhythmias both in the early stage and after the acute event. , 1987, International journal of cardiology.

[167]  F. Spencer,et al.  Low Molecular Weight Heparin and Unfractionated Heparin in the Early Pharmacologic Management of Acute Coronary Syndromes: A Meta-analysis of Randomized Clinical Trials , 2001, Journal of Thrombosis and Thrombolysis.

[168]  V. Fuster,et al.  The Unstable Atherosclerotic Plaque: Clinical Significance and Therapeutic Intervention , 1997, Thrombosis and Haemostasis.

[169]  R. W. Brower,et al.  RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator , 1985, The Lancet.

[170]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[171]  D. Chamberlain,et al.  Five hundred patients with myocardial infarction monitored within one hour of symptoms. , 1983, British medical journal.

[172]  R. Califf,et al.  Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial , 1991, Circulation.

[173]  N. Madias,et al.  Precordial ST-segment mapping. 2. Effects of oxygen inhalation on ischemic injury in patients with acute myocardial infarction. , 1976, Circulation.

[174]  R. Welsh,et al.  Meta-analysis of randomized trials comparing enoxaparin versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction. , 2003, The American journal of cardiology.

[175]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[176]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[177]  P. Held Effects of nitrates on mortality in acute myocardial infarction and in heart failure. , 1992, British journal of clinical pharmacology.

[178]  M. Millar-Craig,et al.  Reduction in treatment delay by paramedic ECG diagnosis of myocardial infarction with direct CCU admission , 1997, Heart.

[179]  K. Lee,et al.  Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. , 1996, Circulation.

[180]  Todd Zaayer Accuracy of computer interpreted electrocardiography in selecting patients for thrombolytic therapy , 1992 .

[181]  A. Jaffe,et al.  Determinants of hemodynamic compromise with severe right ventricular infarction. , 1990, Circulation.

[182]  C. Granger,et al.  Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study. , 2003, European heart journal.

[183]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[184]  M. Davies,et al.  Anatomic features in victims of sudden coronary death. Coronary artery pathology. , 1992, Circulation.

[185]  K. Chacko Diagnosing and managing unstable angina. , 1995, Circulation.

[186]  Eorge,et al.  CARDIAC-SPECIFIC TROPONIN I LEVELS TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES , 2000 .

[187]  H. Suryapranata,et al.  Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. , 2000, European heart journal.

[188]  H. White,et al.  One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.

[189]  S. Yusuf,et al.  Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis , 2000, The Lancet.

[190]  L. Passos,et al.  Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. , 2003, The American journal of cardiology.

[191]  M. Simoons,et al.  Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, The Netherlands. , 1995, The British journal of general practice : the journal of the Royal College of General Practitioners.

[192]  E. Topol Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade , 1998, The Lancet.

[193]  M. Smyth,et al.  A comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatography. , 1999, Journal of pharmaceutical and biomedical analysis.

[194]  V. Fuster,et al.  Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.

[195]  E. Topol Inflammation and embolization in ischemic heart disease. , 2000, The Journal of invasive cardiology.

[196]  R. Collins,et al.  Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review , 2002, The Lancet.

[197]  H. Lambertz,et al.  THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY , 1988, The Lancet.

[198]  J P Ornato,et al.  Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest Recommended Citation Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest , 2022 .

[199]  B H Rowe,et al.  Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes. , 2003, The Cochrane database of systematic reviews.

[200]  H. Wellens,et al.  Observations on Patients with Primary Ventricular Fibrillation Complicating Acute Myocardial Infarction , 1975, Circulation.

[201]  P. R. R. Ecurrent,et al.  EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .

[202]  A. Laggner,et al.  Ramipril Prior to Thrombolysis Attenuates the Early Increase of PAI-1 in Patients with Acute Myocardial Infarction , 2002, Thrombosis and Haemostasis.

[203]  D. Julian,et al.  Sudden death in the community - The arrhythmia causing cardiac arrest and results of immediate resuscitation , 1992 .

[204]  Ayah E. Johnson,et al.  Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. , 1999, JAMA.

[205]  T. Aufderheide,et al.  Planning, Implementation, and Process Monitoring for Prehospital 12-Lead ECG Diagnostic Programs , 1996, Prehospital and Disaster Medicine.

[206]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico. GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction , 1994, The Lancet.

[207]  B. Haynes,et al.  A rural emergency medical technician with selected advanced skills. , 1999, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[208]  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. , 1994, BMJ.

[209]  Assent investigators Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction , 2001, The Lancet.

[210]  G Barbash,et al.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial , 1999, The Lancet.

[211]  A. Jacobs,et al.  Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the Thrombolysis in Myocardial Infarction [TIMI] II trial) , 1993 .

[212]  J. Rawles,et al.  Controlled trial of oxygen in uncomplicated myocardial infarction. , 1976, British medical journal.

[213]  K. Coyne,et al.  Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II) , 2002 .

[214]  B. Magnani,et al.  Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: Results from the Fosinopril in Acute Myocardial Infarction Study , 1998 .

[215]  Eric J Topol,et al.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[216]  A. Jacobs,et al.  Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group. , 1993, The American journal of cardiology.

[217]  E. Gurfinkel,et al.  Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. , 1995, Journal of the American College of Cardiology.

[218]  L. Wilkins Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[219]  Deepak L. Bhatt,et al.  Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes , 2001, Circulation.

[220]  J. Mcmanus Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994 , 1994 .

[221]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[222]  E. Sowton,et al.  Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: a placebo-controlled arteriographic coronary recanalization study. , 1987, Journal of the American College of Cardiology.

[223]  R. F. Kelly,et al.  Effect of 100% oxygen administration on infarct size and left ventricular function in a canine model of myocardial infarction and reperfusion. , 1995, American heart journal.

[224]  W. Rosamond,et al.  Prehospital delay in patients with acute coronary heart disease: concordance between patient interviews and medical records. , 1998, American heart journal.

[225]  W. Weaver,et al.  The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? National Registry of Myocardial Infarction 2 Investigators. , 1997, Journal of the American College of Cardiology.

[226]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[227]  J. W. Schaeffer,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article , 2002 .

[228]  C. Fry,et al.  Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.

[229]  R. Califf,et al.  A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. , 1997 .

[230]  Mylan C. Cohen,et al.  Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. , 1997, The American journal of cardiology.

[231]  B. Cason,et al.  Hyperoxemic reperfusion does not increase myocardial infarct size. , 1991, American Journal of Physiology.

[232]  Dwight Lemon,et al.  Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 , 1987 .

[233]  S. Yusuf,et al.  Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups , 2002, Circulation.

[234]  H. Swan,et al.  Effect of Oxygen Breathing on Pacing‐Induced Angina Pectoris and other Manifestations of Coronary Insufficiency , 1972, Circulation.

[235]  Emeras Collaborative Group Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction , 1993, The Lancet.

[236]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[237]  Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group. , 1992, BMJ.

[238]  P. Touboul,et al.  Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial , 2003, Circulation.

[239]  W. R. Murdoch,et al.  Circulatory and Metabolic Effects of Oxygen in Myocardial Infarction , 1968, British medical journal.

[240]  J. Murray,et al.  ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. , 1999, Journal of the American College of Cardiology.

[241]  S. Malhotra,et al.  A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial). , 2001, International journal of clinical pharmacology and therapeutics.

[242]  S. Silvers,et al.  Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting With Suspected Acute Myocardial Infarction or Unstable Angina. , 2000, Annals of emergency medicine.

[243]  J. Herlitz,et al.  Prognostic value of biochemical markers, 12‐lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome , 2004, Journal of internal medicine.

[244]  Richard P. Lewis,et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[245]  E. Antman,et al.  Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. , 1999, Circulation.

[246]  J. Rawles,et al.  Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). , 1997, Journal of the American College of Cardiology.

[247]  A. Van der Laarse,et al.  Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction. , 1990, The American journal of cardiology.

[248]  M. Aschermann,et al.  Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). , 2003, The Canadian journal of cardiology.

[249]  W. Weaver,et al.  Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. , 1996, Circulation.

[250]  S. Yusuf,et al.  Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes , 2003, Circulation.

[251]  Jun Zhu,et al.  Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. , 2005, JAMA.

[252]  R. Califf,et al.  Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. , 2004, JAMA.

[253]  T. Hedner,et al.  Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction. , 1996, Heart & lung : the journal of critical care.

[254]  H. White,et al.  Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. , 2002, American heart journal.

[255]  D. Freimark,et al.  Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. , 2002, The American journal of cardiology.

[256]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.

[257]  D. Foster,et al.  Prehospital recognition of AMI using independent nurse/paramedic 12-lead ECG evaluation: impact on in-hospital times to thrombolysis in a rural community hospital. , 1994, The American journal of emergency medicine.

[258]  R. Califf,et al.  Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. , 1999, The American journal of cardiology.

[259]  W. Gibler,et al.  Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: a preliminary report from the Cincinnati Heart Project. , 1992, American heart journal.

[260]  M. Simoons Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial , 2001, The Lancet.

[261]  B. Nallamothu,et al.  Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? , 2003, The American journal of cardiology.

[262]  P. Armstrong,et al.  Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction , 2003, Circulation.

[263]  C. Vrints,et al.  Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. , 1999, Circulation.

[264]  GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. , 1994, Lancet.

[265]  M. Kayıkçıoğlu,et al.  The effect of statin therapy on ventricular late potentials in acute myocardial infarction. , 2003, International journal of cardiology.

[266]  Salim Yusuf,et al.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study , 2001, The Lancet.

[267]  K. Fox,et al.  Chest pain in women: clinical, investigative, and prognostic features , 1994, BMJ.

[268]  M. Feldman,et al.  Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution. , 1999, The American journal of cardiology.

[269]  Daniel B. Mark,et al.  Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. , 1994, Circulation.

[270]  F. Werf Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial , 1999, The Lancet.

[271]  E. Topol Thrombolytic or Angioplasty Therapy of Evolving Myocardial Infarction? , 1998, Journal of Thrombosis and Thrombolysis.

[272]  W. Rogers,et al.  Consultation before thrombolytic therapy in acute myocardial infarction. Second National Registry of Myocardial Infarction (NRMI 2) Investigators. , 1999, The American journal of cardiology.

[273]  P. Libby,et al.  High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study , 2003, Circulation.

[274]  M. Olschewski,et al.  Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. , 1993, The New England journal of medicine.

[275]  R. Wilcox,et al.  Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence International Joint Efficacy Comparison of Thrombolytics , 1995, The Lancet.

[276]  S. Kelsey,et al.  Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): report from the National Heart, Lung, and Blood Institute PTCA Registry. , 1984, The American journal of cardiology.

[277]  R. Virmani,et al.  Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. , 1995, Circulation.

[278]  Aims Trial Study Group EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL , 1988, The Lancet.